Similar to our results with pancreatic cancer, several studies have found SPOP to be downregulated in primary tumors of non-small cell lung cancer28, liver cancer29, osteosarcoma30, colorectal cancer31, and gastric cancer32, and this downregulation was associated with poor prognosis. This evidence concerns the gene SPOP and familial pancreatic carcinoma.